Tomorrow, Sir Hunt of the Royal Society and a 2001 Nobel laureate in Physiology or Medicine, will speak on the topic "Lessons from a Life in Science", while Prof. Sharpless, of the Scripps Research ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company SVF Vaccines has appointed Dr Gaston Picchio as acting CEO. He will assume the position with effect from ...

New research co-authored by Duncan Watson-Parris of UC San Diego’s Scripps Institution of Oceanography and the Halıcıoğlu ...

Researchers found that caffeine blocks alcohol’s ability to increase dopamine in brain reward areas, potentially reducing ...

Collaborative among FAU, Scripps, Max Planck and more intends to champion research, programming to make County hub of 'The ...

The partners are advancing a pipeline of engineered DNase I therapies designed to work with CAR T cells to kill tumor cells.

The expertise of co-author Jin-Quan Yu, a chemist at the Scripps Research Institute, was brought in to expand the repertoire of C-H methods that could be applied to the synthesis. A human story Scott ...

The Molecular Frontiers Symposium, organized by the globally renowned Molecular Frontiers Foundation - founded by the Royal ...

John Sclater, a geophysicist at UC San Diego’s Scripps Institution of Oceanography and a member of the first wave of ...

Company is advancing DNase-based oncology program towards clinical proof-of-concept studies in multiple indications FRAMINGHAM, MA / ACCESSWIRE / November 7, 2024 / Xenetic Biosciences, Inc.

Xenetic (XBIO) Biosciences has extended its previously announced Research Funding and Option Agreement with The Scripps Research Institute to advance the development of the Company’s program on the ...

To help address this growing challenge, scientists at Scripps Research and its nonprofit drug development arm, the Calibr-Skaggs Institute for Innovative Medicines, are advancing novel ...